IMRX: immuneering.com Net earnings per share for the last 12 months

Symbol and logo of brand Immuneering (IMRX)

Immuneering Corporation develops targeted oncology drugs leveraging an IT platform for bio-network analysis, while current reserves allow research to proceed without funding shortages. The current annual net income per share reflects a balance of fundamental forces, where -1.03 serves as the base parameter value. However, the lack of revenue makes the issuer's stability dependent on external capital and the success of clinical trials.

IMRX (Immuneering Corporation) Net earnings per share (EPS TTM) history from 07/04/2022 to 11/17/2026

Analytical breakdowns for Immuneering Corporation

- share price and expert price forecast:
Basic company analysis:Immuneering Corporation - IMRX
Manufactured products of Immuneering Corp

The specifics of oncology clinical trial outsourcing at Immuneering Corporation (IMRX) are directly reflected in the rolling annual EPS trend, linking operating expenses to overall efficiency. This indicator calculates net income divided by the total number of shares over a year, which filters out market noise and determines whether the current trend represents fundamental business growth or a temporary rebound of a risky asset.

Who Immuneering Corporation competes with

GMAB: Net earnings per share for the last 12 months|Earnings per share for the trailing year EXEL (Exelixis Corp)|NUVL (Nuvalent) - Net earnings per share for the last 12 months|KYMR: Earnings per share for the last four quarters|IDYA (IDEAYA Corp) - Net earnings per share (EPS TTM)|Net earnings per share (EPS TTM) enliventherapeutics.com|Earnings per share for the last twelve months ORIC Pharmaceuticals, Inc. (ORIC)|RLAY (Relay Therapeutics, Inc.) - Earnings per share for the trailing year|Net earnings per share (EPS TTM) NRIX (Nurix Therapeutics Inc)|Net earnings per share for the trailing year Tyra Bio|Verastem Oncology - Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months Monte Rosa Therapeutics, Inc.|CGEM (Cullinan Therapeutics) - Net earnings per share for the last 12 months|CCCC: Earnings per share for the last four quarters|BDTX (blackdiamondtherapeutics.com) - Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months Repare Rx RPTX|Net earnings per share (EPS TTM) PMVP|Karyopharm - Earnings per share for the last 12 months|Propanc Biopharma Inc - Net earnings per share for the last 12 months|Earnings per share for the trailing year BGMS|AADI: Net earnings per share for the last 12 months|aileronrx.com - Earnings per share for the last four quarters|BPMC: Net earnings per share (EPS TTM)|GlycoMimetics Inc. - Earnings per share for the trailing year|SWTX (SpringWorks Therapeutics, Inc) - Net earnings per share (EPS TTM)